Timing of ischemic onset estimated from the electrocardiogram is better than historical timing for predicting outcome after reperfusion therapy for acute anterior myocardial infarction: A DANish trial in Acute Myocardial Infarction 2 (DANAMI-2) substudy

American Heart Journal

Volumn 154, Issue 1, 2007, Pages 61.e1-61.e8

  Sejersten, Maria ^a   Ripa, Rasmus S ^a   Maynard, Charles ^b   Grande, Peer ^a   Andersen, Henning Rud ^c   Wagner, Galen S ^d   Clemmensen, Peter ^a  

^a University of Copenhagen   (Denmark)

^b UNIVERSITY OF WASHINGTON   (United States)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

ADULT; ARTICLE; CONFOUNDING VARIABLE; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; ST SEGMENT ELEVATION; TREATMENT OUTCOME;

EID: 34250308798     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.04.003     Document Type: Article

References (25)

1. Videbaek J., and Madsen M. 2004 HjerteStatistik. 1st. ed (2004), Hjerteforeningen i samarbejde med Statens Institut for Folkesundhed, København, Denmark
2. Boersma E., Maas A.C., Deckers J.W., et al. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 348 (1996) 771-775
3. De Luca G., Suryapranata H., Ottervanger J.P., et al. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation 109 (2004) 1223-1225
4. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 110 (2004) e82-e292
5. Van de Werf F., Ardissino D., Betriu A., et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 24 (2003) 28-66
6. Nallamothu B.K., Bates E.R., Herrin J., et al. Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation 111 (2005) 761-767
7. Bradley E.H., Herrin J., Wang Y., et al. Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med 355 (2006) 2308-2320
8. Anderson S.T., Wilkins M., Weaver W.D., et al. Electrocardiographic phasing of acute myocardial infarction. J Electrocardiol 25 Suppl (1992) 3-5
9. Wilkins M.L., Pryor A.D., Maynard C., et al. An electrocardiographic acuteness score for quantifying the timing of a myocardial infarction to guide decisions regarding reperfusion therapy. Am J Cardiol 75 (1995) 617-620
10. Corey K.E., Maynard C., Pahlm O., et al. Combined historical and electrocardiographic timing of acute anterior and inferior myocardial infarcts for prediction of reperfusion achievable size limitation. Am J Cardiol 83 (1999) 826-831
11. Andersen H.R., Nielsen T.T., Vesterlund T., et al. Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction: rationale and design of the DANish trial in Acute Myocardial Infarction-2 (DANAMI-2). Am Heart J 146 (2003) 234-241
12. Andersen H.R., Nielsen T.T., Rasmussen K., et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 349 (2003) 733-742
13. Gambill C.L., Wilkins M.L., Haisty Jr. W.K., et al. T wave amplitudes in normal populations. Variation with ECG lead, sex, and age. J Electrocardiol 28 (1995) 191-197
14. Hindman N.B., Schocken D.D., Widmann M., et al. Evaluation of a QRS scoring system for estimating myocardial infarct size. V. Specificity and method of application of the complete system. Am J Cardiol 55 (1985) 1485-1490
15. Heden B., Ripa R., Persson E., et al. A modified Anderson-Wilkins electrocardiographic acuteness score for anterior or inferior myocardial infarction. Am Heart J 146 (2003) 797-803
16. Aldrich H.R., Wagner N.B., Boswick J., et al. Use of initial ST-segment deviation for prediction of final electrocardiographic size of acute myocardial infarcts. Am J Cardiol 61 (1988) 749-753
17. Clemmensen P., Grande P., Aldrich H.R., et al. Evaluation of formulas for estimating the final size of acute myocardial infarcts from quantitative ST-segment elevation on the initial standard 12-lead ECG. J Electrocardiol 24 (1991) 77-83
18. Juergens C.P., Fernandes C., Hasche E.T., et al. Electrocardiographic measurement of infarct size after thrombolytic therapy. J Am Coll Cardiol 27 (1996) 617-624
19. Engblom H., Wagner G.S., Setser R.M., et al. Quantitative clinical assessment of chronic anterior myocardial infarction with delayed enhancement magnetic resonance imaging and QRS scoring. Am Heart J 146 (2003) 359-366
20. Clemmensen P., Grande P., Saunamaki K., et al. Effect of intravenous streptokinase on the relation between initial ST-predicted size and final QRS-estimated size of acute myocardial infarcts. J Am Coll Cardiol 16 (1990) 1252-1257
21. Barbagelata A., Di M., Carli F., Califf R.M., et al. Electrocardiographic infarct size assessment after thrombolysis: insights from the Acute Myocardial Infarction STudy, ADenosine (AMISTAD) trial. Am Heart J 150 (2005) 659-665
22. Vejlstrup N., Clemmensen P., Steinmetz E., et al. Blinded end point adjudication in the Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction (DANAMI-2 trial). Heart Drug 3 (2003) 127-133
23. Schomig A., Ndrepepa G., Mehilli J., et al. Therapy-dependent influence of time-to-treatment interval on myocardial salvage in patients with acute myocardial infarction treated with coronary artery stenting or thrombolysis. Circulation 108 (2003) 1084-1088
24. Zijlstra F., Patel A., Jones M., et al. Clinical characteristics and outcome of patients with early (2 h), intermediate (2-4 h) and late (4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J 23 (2002) 550-557
25. Ripa R.S., Persson E., Heden B., et al. Comparison between human and automated electrocardiographic waveform measurements for calculating the Anderson-Wilkins acuteness score in patients with acute myocardial infarction. J Electrocardiol 38 (2005) 96-99